A Look at the Technicals For Nanobiotix SA (ENXTPA:NANO)
April 12, 2017
Investors may be interested in viewing the Gross Margin score on shares of Nanobiotix SA (ENXTPA:NANO). The name currently has a score of 63.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative. The low score of 63.00000 for Nanobiotix SA indicates a top score for stability and growth.
Checking in on some valuation rankings, Nanobiotix SA (ENXTPA:NANO) has a Value Composite score of 91. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 92.
After a recent scan, we can see that Nanobiotix SA (ENXTPA:NANO) has a Shareholder Yield of -0.100860 and a Shareholder Yield (Mebane Faber) of 0.21020. The first value is calculated by adding the dividend yield to the percentage of repurchased shares. The second value adds in the net debt repaid yield to the calculation. Shareholder yield has the ability to show how much money the firm is giving back to shareholders via a few different avenues. Companies may issue new shares and buy back their own shares. This may occur at the same time. Investors may also use shareholder yield to gauge a baseline rate of return.
At the time of writing, Nanobiotix SA (ENXTPA:NANO) has a Piotroski F-Score of 2. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.
Nanobiotix SA (ENXTPA:NANO) has a current ERP5 Rank of 14346 . The ERP5 Rank may assist investors with spotting companies that are undervalued. This ranking uses four ratios. These ratios are Earnings Yield, ROIC, Price to Book, and 5 year average ROIC. When looking at the ERP5 ranking, it is generally considered the lower the value, the better.
Shifting gears, we can see that Nanobiotix SA (ENXTPA:NANO) has a Q.i. Value of 76.00000. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be.